Consumption methods — smoking, vape, edibles, oil

How strong and how long does each method act? This hub compares smoking, vape, edibles and oil with guides, calculators and studies.

We compare consumption methods — vaping, smoking, edibles, tinctures, topicals — by onset, duration, bioavailability and harm-reduction profile. Recommendations follow Sucht Schweiz and FOPH guidance, including dosage and interaction risks.

Definition and context

Consumption methods differ in onset, duration, and physical strain: vaporizing, smoking, oral ingestion via oils and capsules, and topical application.

The situation in Switzerland

In Switzerland, CBD products are not authorized as food; oils are therefore sold without consumption recommendations. For road traffic, the national THC limit applies regardless of the consumption method.

What this means in practice

Vaporizing takes effect within minutes and is significantly lower in harmful substances than combustion. Oral ingestion has a delayed onset of 30–90 minutes and lasts longer—here, redosing too quickly is the most common mistake. Those who mix with tobacco add its associated risks; tobacco-free alternatives are the simplest improvement.

Frequently asked questions

What is healthier: smoking or vaporizing?

Vaporizing. No combustion byproducts are created, and the terpenes are largely preserved.

How long does it take to feel the effects?

A few minutes when inhaled, 30–90 minutes when taken orally. Therefore, dose patiently with oils and edibles.

What vaporizer temperature is recommended?

180–200 °C is a good range: high enough to release the active ingredients, low enough to preserve the terpenes.

Background and development

Swiss cannabis regulation is evolving rapidly under the federal Narcotics Act (BetmG). Historically, Switzerland set a progressive 1% total THC limit in 2011 for non-medical cannabis, sparking a boom in low-THC CBD products. While medical cannabis regulations were liberalized on 1 August 2022—allowing Swiss doctors to prescribe medical THC directly without Swissmedic exceptional permits—recreational high-THC cannabis remains strictly regulated. However, the Federal Office of Public Health (FOPH/BAG) has authorized pioneering pilot trials (such as Weed Care in Basel, Züri Can in Zurich, and trials in Bern, Lausanne, and Geneva) to study regulated sales. Possession of up to 10 grams of cannabis for adult personal consumption remains decriminalized, carrying only a CHF 100 fixed penalty (Ordnungsbusse). Today, these pilot studies run alongside a highly regulated commercial CBD market, bridging the gap between historical prohibition and evidence-based public health models.

Distinctions and misconceptions

Consumers often confuse legal Swiss CBD (under 1% THC) with illicit high-THC cannabis, assuming they share the same legal standing or consumption safety profiles. Another major confusion lies in the distinction between wellness CBD oils and medical-grade preparations prescribed under the August 2022 law. A common false assumption is that consuming non-psychoactive CBD or using vaporizers bypasses the strict road safety rules. In reality, Switzerland maintains a zero-tolerance road traffic limit of 1.5 micrograms of THC per liter of blood. Even high-dose legal CBD products can accumulate enough trace THC to trigger a positive test. Furthermore, many believe Swiss aroma oils are legally classified as food supplements. Actually, Swiss food safety laws prohibit CBD in foodstuffs, meaning these oils are officially marketed for technical or cosmetic purposes, not oral consumption, despite market practice.

Decision guide for Switzerland

When choosing a consumption method, Swiss adults must evaluate their goals against health risks, legal limits, and lifestyle. If respiratory health is your priority, avoid combustion entirely; tobacco-free vaporizing or oral alternatives are the standard. For vaping, invest in a certified dry-herb vaporizer, typically starting around CHF 80 to CHF 300, ensuring precise temperature control. If you choose oral methods, carefully verify the canton's retail source and avoid the temptation of rapid redosing due to the delayed onset. Always assess your transit plans: because the 1.5 µg/L blood THC driving limit is absolute, any method involving THC requires a complete separation from driving. Never purchase unregulated street products, as they bypass the rigorous pesticide and heavy metal testing mandated in Swiss pilot studies and legal CBD channels. Joining a recognized Swiss cannabis members club ensures access to verified, lab-tested products tailored to adult consumer safety standards.

How does the 1.5 µg/L blood THC limit apply if I only consume legal CBD products?

Even though legal Swiss CBD contains less than 1% THC, regular or high-dose consumption can cause trace THC to accumulate in your body. This can result in a blood concentration exceeding the strict Swiss road traffic limit of 1.5 micrograms of THC per liter. If you drive, it is crucial to monitor your consumption carefully, as the law makes no distinction regarding the source of the THC.

Why can I not buy legal cannabis edibles in Swiss grocery stores?

Under Swiss food safety regulations monitored by the Federal Office of Public Health, CBD and THC are not permitted as ingredients in standard food products. Consequently, legal edibles cannot be sold as standard groceries. Instead, regulated high-THC edibles are currently only accessible to registered participants within official canton-approved pilot studies, such as those running in Zurich, Basel, or Bern, where safety and dosage are strictly monitored.

Explore this topic further

These guides explain the background and address practical questions in the Swiss context.

Key figures

  • 220’000+ — Swiss adults regularly consume cannabis (BAG · Suchtmonitoring 2024)
  • 36% — of 15–34 year-olds have tried cannabis (EMCDDA · Country Report Switzerland 2024)
  • CHF 582M — estimated Swiss cannabis black-market revenue per year (Uni Genf · Cannabis Market Estimate 2023)
  • 7 — cities with active or approved pilot projects (BAG · Cannabis Pilotversuche 2026)

Current research

  • Cannabis use in Switzerland — Addiction Monitoring 2024 — Sucht Schweiz, BAG · 2024
  • European Drug Report — Cannabis Chapter — EMCDDA, EUDA · 2024
  • WHO Expert Committee on Drug Dependence — Cannabis Review — WHO ECDD, WHO · 2023

Datasets on this topic